TW200606161A - Muscarinic acetylcholine receptor antagonists - Google Patents
Muscarinic acetylcholine receptor antagonistsInfo
- Publication number
- TW200606161A TW200606161A TW094117162A TW94117162A TW200606161A TW 200606161 A TW200606161 A TW 200606161A TW 094117162 A TW094117162 A TW 094117162A TW 94117162 A TW94117162 A TW 94117162A TW 200606161 A TW200606161 A TW 200606161A
- Authority
- TW
- Taiwan
- Prior art keywords
- receptor antagonists
- acetylcholine receptor
- muscarinic acetylcholine
- muscarinic
- methods
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/08—Bridged systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/16—Central respiratory analeptics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/16—Otologicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/08—Antiallergic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Health & Medical Sciences (AREA)
- Pulmonology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US57532904P | 2004-05-28 | 2004-05-28 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TW200606161A true TW200606161A (en) | 2006-02-16 |
Family
ID=35462875
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TW094117162A TW200606161A (en) | 2004-05-28 | 2005-05-26 | Muscarinic acetylcholine receptor antagonists |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7579345B2 (zh) |
| EP (1) | EP1749012A4 (zh) |
| JP (1) | JP2008501020A (zh) |
| AR (1) | AR048976A1 (zh) |
| PE (1) | PE20060367A1 (zh) |
| TW (1) | TW200606161A (zh) |
| WO (1) | WO2005118594A1 (zh) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AR045914A1 (es) * | 2003-07-17 | 2005-11-16 | Glaxo Group Ltd | Compuesto alcoholico terciario del 8-azoniabiciclo [3.2.1] octano, composicion farmaceutica que lo comprende y su uso para preparar esta ultima |
| BRPI0415281A (pt) * | 2003-10-17 | 2006-12-19 | Glaxo Group Ltd | antagonistas de receptor de acetilcolina muscarìnico |
| AR046225A1 (es) * | 2003-11-04 | 2005-11-30 | Glaxo Group Ltd | Compuesto de 8-azoniabiciclo(3.2.1)octano, composicion farmaceutica para el tratamiento de enfermedades mediadas por receptores de acetilcolina muscarinicos que lo comprende y uso del compuesto para preparar dicha composicion |
| WO2005087236A1 (en) * | 2004-03-11 | 2005-09-22 | Glaxo Group Limited | Novel m3 muscarinic acetylcholine receptor antagonists |
| WO2005095407A1 (en) * | 2004-03-17 | 2005-10-13 | Glaxo Group Limited | M3 muscarinic acetylcholine receptor antagonists |
| TWI363759B (en) | 2004-04-27 | 2012-05-11 | Glaxo Group Ltd | Muscarinic acetylcholine receptor antagonists |
| US7598267B2 (en) * | 2004-05-13 | 2009-10-06 | Glaxo Group Limited | Muscarinic acetylcholine receptor antagonists |
| JP2008520579A (ja) * | 2004-11-15 | 2008-06-19 | グラクソ グループ リミテッド | 新規m3ムスカリン性アセチルコリン受容体アンタゴニスト |
| EP1937267A4 (en) * | 2005-08-02 | 2009-08-26 | Glaxo Group Ltd | M3-MUSCARIN ACETYLCHOLIN RECEPTOR ANTAGONISTS |
| EP1937068A4 (en) * | 2005-08-18 | 2010-08-04 | Glaxo Group Ltd | ANTAGONISTS OF ACETYLCHOLINE MUSCARINIC RECEPTORS |
| BRPI0807615A8 (pt) | 2007-02-23 | 2017-12-05 | Theravance Inc | Compostos de difenilmetil amônico quaternário úteis como antagonistas de receptor muscarínico |
| UY31636A1 (es) | 2008-02-06 | 2009-08-03 | Farmacoforos duales-antagonistas muscarinicos de pde4 | |
| UY31637A1 (es) | 2008-02-06 | 2009-08-03 | Farmacoforos duales-antagonistas muscarinicos de pde4 | |
| TW200946526A (en) | 2008-02-06 | 2009-11-16 | Glaxo Group Ltd | Dual pharmacophores-PDE4-muscarinic antagonistics |
| WO2010094643A1 (en) | 2009-02-17 | 2010-08-26 | Glaxo Group Limited | Quinoline derivatives and their uses for rhinitis and urticaria |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6476046B1 (en) * | 2000-12-04 | 2002-11-05 | Sepracor, Inc. | Diazabicyclo[4.3.0]nonanes, and methods of use thereof |
| US6696462B2 (en) * | 2002-01-31 | 2004-02-24 | Boehringer Ingelheim Pharma Gmbh & Co. Kg | Anticholinergics, processes for the preparation thereof, and pharmaceutical compositions |
-
2005
- 2005-05-26 TW TW094117162A patent/TW200606161A/zh unknown
- 2005-05-26 EP EP05753818A patent/EP1749012A4/en not_active Withdrawn
- 2005-05-26 PE PE2005000591A patent/PE20060367A1/es not_active Application Discontinuation
- 2005-05-26 WO PCT/US2005/018563 patent/WO2005118594A1/en not_active Ceased
- 2005-05-26 US US11/568,909 patent/US7579345B2/en not_active Expired - Fee Related
- 2005-05-26 JP JP2007515340A patent/JP2008501020A/ja active Pending
- 2005-05-26 AR ARP050102174A patent/AR048976A1/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AR048976A1 (es) | 2006-06-14 |
| EP1749012A4 (en) | 2009-07-29 |
| US20070232599A1 (en) | 2007-10-04 |
| EP1749012A1 (en) | 2007-02-07 |
| WO2005118594A1 (en) | 2005-12-15 |
| JP2008501020A (ja) | 2008-01-17 |
| PE20060367A1 (es) | 2006-04-28 |
| US7579345B2 (en) | 2009-08-25 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MY144753A (en) | Muscarinic acetylcholine receptor antagonists | |
| MY143366A (en) | Muscarinic acetylcholine receptor antagonists | |
| TW200600093A (en) | M3 muscarinic acetylcholine receptor antagonists | |
| WO2005046586A8 (en) | M3 muscarinic acetylcholine receptor antagonists | |
| WO2004012684A3 (en) | M3muscarinic acetylcholine receptor antagonists | |
| MXPA06000662A (es) | Antagonistas del receptor muscarinico de acetilcolina. | |
| TW200519109A (en) | Muscarinic acetylcholine receptor antagonists | |
| TW200519108A (en) | Muscarinic acetylcholine receptor antagonists | |
| TW200633715A (en) | Medical combinations | |
| WO2005055941A3 (en) | Novel m3 muscarinic acetylcholine receptor antagonists | |
| WO2005067537A3 (en) | Muscarinic acetylcholine receptor antagonists | |
| WO2005055940A3 (en) | Novel m3 muscarinic acetylcholine receptor antagonists | |
| WO2006065788A3 (en) | Novel muscarinic acetylcholine receptor antagonists | |
| TW200606161A (en) | Muscarinic acetylcholine receptor antagonists | |
| WO2007022351A3 (en) | Muscarinic acetylcholine receptor antagonists | |
| TW200633706A (en) | Medical combinations | |
| WO2006055553A3 (en) | Novel m3 muscarinic acetylcholine receptor antagonists | |
| TW200600500A (en) | M3 muscarinic acetylcholine receptor antagonists | |
| WO2006055503A3 (en) | Novel m3 muscarinic acetylcholine receptor antagonists | |
| WO2006050239A3 (en) | Muscarinic acetylcholine receptor antagonists | |
| WO2005112644A3 (en) | Muscarinic acetylcholine receptor antagonists | |
| WO2005037224A3 (en) | Muscarinic acetylcholine receptor antagonists | |
| WO2007016650A3 (en) | M3 muscarinic acetylcholine receptor antagonists | |
| WO2007016639A3 (en) | M3 muscarinic acetylcholine receptor antagonists | |
| WO2006005057A3 (en) | Muscarinic acetylcholine receptor antagonists |